These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 11819788

  • 1. Antihepatoma effect of alpha-fetoprotein antisense phosphorothioate oligodeoxyribonucleotides in vitro and in mice.
    Wang XW, Yuan JH, Zhang RG, Guo LX, Xie Y, Xie H.
    World J Gastroenterol; 2001 Jun; 7(3):345-51. PubMed ID: 11819788
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antitumor effect of bcl-2 antisense phosphorothioate oligodeoxynucleotides on human renal-cell carcinoma cells in vitro and in mice.
    Uchida T, Gao JP, Wang C, Satoh T, Itoh I, Muramoto M, Hyodo T, Irie A, Akahoshi T, Jiang SX, Kameya T, Baba S.
    Mol Urol; 2001 Jun; 5(2):71-8. PubMed ID: 11690551
    [Abstract] [Full Text] [Related]

  • 4. Combined effect of alpha-fetoprotein antisense oligodeoxy-nucleotides and 5-fluorouracil on human hepatoma cell growth.
    Wang X, Zhang R, Xie H.
    Chin Med J (Engl); 1999 Aug; 112(8):743-6. PubMed ID: 11601286
    [Abstract] [Full Text] [Related]

  • 5. [The effect of antisense H-ras on growth and metastasis of a high metastatic tumor model of human hepatoma in nude mice LCI-D20].
    Liao Y, Tang Z, Sun F.
    Zhonghua Yi Xue Za Zhi; 1996 Sep; 76(9):650-3. PubMed ID: 9275544
    [Abstract] [Full Text] [Related]

  • 6. Inhibiting survivin expression enhances TRAIL-induced tumoricidal activity in human hepatocellular carcinoma via cell cycle arrest.
    He SQ, Rehman H, Gong MG, Zhao YZ, Huang ZY, Li CH, Zhang WG, Chen XP.
    Cancer Biol Ther; 2007 Aug; 6(8):1247-57. PubMed ID: 17700059
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Tumor-targeted gene therapy using Adv-AFP-HRPC/IAA prodrug system suppresses growth of hepatoma xenografted in mice.
    Dai M, Liu J, Chen DE, Rao Y, Tang ZJ, Ho WZ, Dong CY.
    Cancer Gene Ther; 2012 Feb; 19(2):77-83. PubMed ID: 21959967
    [Abstract] [Full Text] [Related]

  • 9. Downregulation of alpha-fetoprotein siRNA inhibits proliferation of SMMC-7721 cells.
    Wang YS, Ma XL, Qi TG, Liu XD, Meng YS, Guan GJ.
    World J Gastroenterol; 2005 Oct 14; 11(38):6053-5. PubMed ID: 16273624
    [Abstract] [Full Text] [Related]

  • 10. Reduction of tumorigenicity of SMMC-7721 hepatoma cells by vascular endothelial growth factor antisense gene therapy.
    Tang YC, Li Y, Qian GX.
    World J Gastroenterol; 2001 Feb 14; 7(1):22-7. PubMed ID: 11819727
    [Abstract] [Full Text] [Related]

  • 11. Selective inhibition of hepatoma cells using diphtheria toxin A under the control of the promoter/enhancer region of the human alpha-fetoprotein gene.
    Kunitomi M, Takayama E, Suzuki S, Yasuda T, Tsutsui K, Nagaike K, Hiroi S, Tadakuma T.
    Jpn J Cancer Res; 2000 Mar 14; 91(3):343-50. PubMed ID: 10760695
    [Abstract] [Full Text] [Related]

  • 12. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
    Ido A, Uto H, Moriuchi A, Nagata K, Onaga Y, Onaga M, Hori T, Hirono S, Hayashi K, Tamaoki T, Tsubouchi H.
    Cancer Res; 2001 Apr 01; 61(7):3016-21. PubMed ID: 11306481
    [Abstract] [Full Text] [Related]

  • 13. Inhibitory effect of EGFR antisense oligodeoxynucleotide on human hepatoma cell line.
    Gong ZB, Liu JM, Li YM.
    Hepatobiliary Pancreat Dis Int; 2005 Aug 01; 4(3):433-6. PubMed ID: 16109531
    [Abstract] [Full Text] [Related]

  • 14. Inhibitory effect of antisense vascular endothelial growth factor RNA on the profile of hepatocellular carcinoma cell line in vitro and in vivo.
    Hao JH, Yu M, Li HK, Shi YR, Li Q, Hao XS.
    World J Gastroenterol; 2006 Feb 21; 12(7):1140-3. PubMed ID: 16534861
    [Abstract] [Full Text] [Related]

  • 15. [An EGFR antisense oligodeoxynucleotides and its phosphorothioate analogue inhibit the growth of human hepatocarcinoma BEL-7404 cells].
    Lin JQ, Xu ZS, Zhang HY, Yang ZW, Xu YH.
    Shi Yan Sheng Wu Xue Bao; 1995 Sep 21; 28(3):241-6. PubMed ID: 8571707
    [Abstract] [Full Text] [Related]

  • 16. Cell-specific expression of artificial microRNAs targeting essential genes exhibit potent antitumor effect on hepatocellular carcinoma cells.
    Mao C, Liu H, Chen P, Ye J, Teng L, Jia Z, Cao J.
    Oncotarget; 2015 Mar 20; 6(8):5707-19. PubMed ID: 25691059
    [Abstract] [Full Text] [Related]

  • 17. Beta-catenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts.
    Green DW, Roh H, Pippin JA, Drebin JA.
    J Surg Res; 2001 Nov 20; 101(1):16-20. PubMed ID: 11676549
    [Abstract] [Full Text] [Related]

  • 18. Modulation of apoptosis, tumorigenesity and metastatic potential with antisense H-ras oligodeoxynucleotides in a high metastatic tumor model of hepatoma: LCI-D20.
    Liao Y, Tang ZY, Ye SL, Liu KD, Sun FX, Huang Z.
    Hepatogastroenterology; 2000 Nov 20; 47(32):365-70. PubMed ID: 10791191
    [Abstract] [Full Text] [Related]

  • 19. The effect of p21 antisense oligodeoxynucleotides on the radiosensitivity of nasopharyngeal carcinoma cells with normal p53 function.
    Liu XF, Xia YF, Li MZ, Wang HM, He YX, Zheng ML, Yang HL, Huang WL.
    Cell Biol Int; 2006 Mar 20; 30(3):283-7. PubMed ID: 16448826
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the inhibitory effect of antisense oligodeoxynucleotides on the growth of hepatitis C-associated hepatocellular carcinoma cells in vitro.
    Amin MA, Awadein MR, Gabr H.
    Chin J Dig Dis; 2005 Mar 20; 6(3):142-8. PubMed ID: 16045605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.